8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001104659-15-085976
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading a15-25314_18k.htm…